BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 193 filers reported holding BEAM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,710,445 | -24.7% | 694,821 | -0.1% | 0.27% | -15.1% |
| Q2 2023 | $22,204,793 | +4.3% | 695,421 | 0.0% | 0.32% | +2.6% |
| Q1 2023 | $21,293,791 | -21.9% | 695,421 | -0.2% | 0.31% | -14.6% |
| Q4 2022 | $27,248,758 | +0.0% | 696,721 | +21.9% | 0.36% | -7.4% |
| Q3 2022 | $27,237,000 | +22.9% | 571,721 | -0.2% | 0.39% | +24.9% |
| Q2 2022 | $22,166,000 | -33.6% | 572,621 | -1.8% | 0.31% | -19.3% |
| Q1 2022 | $33,396,000 | -31.6% | 582,821 | -4.9% | 0.39% | -22.9% |
| Q4 2021 | $48,836,000 | -8.4% | 612,821 | 0.0% | 0.50% | -7.0% |
| Q3 2021 | $53,321,000 | -32.4% | 612,821 | 0.0% | 0.54% | -29.7% |
| Q2 2021 | $78,876,000 | +73.9% | 612,821 | +8.1% | 0.77% | +60.4% |
| Q1 2021 | $45,368,000 | +40.0% | 566,821 | +42.8% | 0.48% | +29.4% |
| Q4 2020 | $32,396,000 | – | 396,821 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
| PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
| HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
| DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
| Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
| Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
| HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
| Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
| Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |